Healthcare | Thursday 12 February, 2015 2:33 pm |

Dubai will host Pharmaceutical Commercial Excellence MENA Congress next week on 17-18 February 2015, a number of pharmaceutical experts will discuss the opportunities, challenges and regulations in pharmaceutical industry across MENA region, the processes that impact market access to reach commercial excellence, enabling market growth for pharma companies to ensure commercial excellence.

The list of speakers include decision makers and influencers drive commercial excellence from major international Pharma and healthcare products organizations include: “Julphar”, “Pfizer”, “Novartis Pharma Services AG “, “Pharmax Pharmaceuticals FZ LLC”, “Bayer”, “Baxter Healthcare”, “MEDA Pharmaceuticals”, “Baxter Healthcare”, “Johnson and Johnson”, “Astra Zeneca Biopharmaceuticals”, “Hospira”, and more.

The event sponsored by a number of leading company such as: “IMS Health” the world’s leading information, services and technology company dedicated to making healthcare perform better, “Elsevier” is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, “HLOUL” a member of Integrated Pharma Solutions Holding, is set by domain experts in Information Solutions and Business Intelligence applications, and organized by Maarefah a world-class events, training and association management company.

The pharmaceutical industry in the MENA region continues to show impressive growth numbers. From a pharmaceutical market perspective, a recent IMS report has estimated that the Middle East market is expected to grow from $16bn in 2013 to $26bn in 2017. This 12-14% growth rate is amongst the highest in the world, and with the extent of growth anticipated in the Middle East pharmaceutical market, companies are striving to adapt their commercial models for competitive advantage.

The Pharmaceutical Commercial Excellence MENA Congress will reflect current market changes, impact of new information and share peer-to- peer strategies on how to increase profits, and overcoming the most pressing issues facing pharmaceutical companies today.